CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1965; 15:283-284
doi: 10.3322/canjclin.15.6.283
© 1965 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coleman, S. A.
Right arrow Articles by Erickson, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coleman, S. A.
Right arrow Articles by Erickson, C. C.

CA: A Cancer Journal for Clinicians, Vol 15, 283-284, Copyright © 1965 by American Cancer Society


Cytologic Detection of Adenocarcinoma

Sidney A. Coleman M.D.1, Irma F. Rube M.S.2, and Cyrus C. Erickson M.D.3

1 Associate Professor of Pathology, University of Tennessee School of Basic Medical Sciences, Memphis, Tennessee.
2 Assistant Professor of Pathology, University of Tennessee School of Basic Medical Sciences.
3 Professor of Pathology, University of Tennessee School of Basic Medical Services.

1. Cytologic examinations were successful in detecting 71% of the endometrial and 90% of endocervical adenocarcinomas in population screening with routine vaginal aspiration smears. In the resident population subjected to morbidity analysis of all cancers and upon removal of screening errors from the test, an accuracy of 78% may be expected from population screening.

2. In a high percentage of the patients confirmed as having adenocarcinoma of the endometrium, symptoms were present at the time of cytologic examination. The average age was 59.77 years.

3. The glandular origin of the atypical cells was recognized in 94% of the cases so that a recommendation of endometrial scraping could be made for definitive diagnosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by American Cancer Society.